Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
6d
Amarillo Biosciences (OTCMKTS:AMAR) recently entered into a Memorandum of Understanding (MOU) with Taiwan Tanabe Seiyaku Co., Ltd., a corporation majority-owned by Mitsubishi Tanabe Pharma Corporation ...
Through collaborations with Bayer, Novo Nordisk, Evotec, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries to accelerate the translation of condensate biology into medicine for ...
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial ...
In its third-quarter results update, the company confirmed that it is halting further development of fasinumab, an NGF drug partnered with Teva and Mitsubishi Tanabe Pharma that was in phase 3 ...
"Johnson & Johnson and Mitsubishi Tanabe Pharma’s Stelara (ustekinumab) and Eli Lilly and Sumitomo Dainippon Pharma’s Trulicity (dulaglutide) are ranked ninth and tenth,” Sabaratnam says.
Mitsubishi is in the process of selling its forklift unit, Tokyo-listed Mitsubishi Logisnext, amid a corporate efficiency push, Nikkei reports. Financial advisors are chosen to move ahead with the ...
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback